Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

TRDATRDA
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ENTRADA THERAPEUTICS INC

JPMORGAN CHASE & CO holds 496,457 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $3.8M as of 2026-Q2. The position was increased (+3243.8% shares). TRDA represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$3.8M

Current Shares

496,457

Total Value Change

+$3.2M

Total Shares Change

+460,987

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
496,457
+3243.8%
$3.8M0.0%$7.36
43
2026-Q1
Decreased
14,847
-79.0%
$174,7490.0%$11.85
0
2025-Q4
Decreased
70,761
-73.6%
$727,4230.0%$10.09
0
2025-Q3
Increased
267,756
+1569.9%
$1.6M0.0%$5.84
28
2025-Q2
Increased
16,034
+9.0%
$107,7480.0%$6.91
16
2025-Q1
Decreased
14,706
-58.5%
$132,9420.0%$9.56
0
2024-Q4
New
35,470
-
$613,2760.0%$17.37
37

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used